+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in sepsis research: novel biomarkers and therapeutic targets

Recent advances in sepsis research: novel biomarkers and therapeutic targets

Current Medicinal Chemistry 18(21): 3211-3225

Sepsis remains a common cause of death in the intensive care units worldwide. However, in the last decade a significant development could be noticed in sepsis research regarding diagnostic markers that can help the physicians to recognize the disease in the early phase, which is the clue of the successful treatment of sepsis. This development provided the identification of new molecules and structures (i.e. cytokines, cell surface markers, receptors) that are potential biomarkers of sepsis in the clinical settings. Besides, the advance in the understanding of the pathophysiologic, immunologic and biochemical pathway of sepsis has made the way for assignment of new drug targets in the therapy of sepsis. This review aims to provide a summary about these novelties regarding our knowledge about sepsis published in the medical literature recently. We will describe the presumed pathophysiological role and diagnostic value of sepsis markers that are used even more widely in the clinical practice (i.e. procalcitonin, IL-6), summarize the data regarding the sepsis marker candidates that are investigated in some initial study (i.e. matrix metalloproteinases, microRNA fingerprints), and we will discuss substances that may be specific markers for certain organ failures related to sepsis (i.e. neutrophil gelatinase-derived lipocalin in acute renal failure). Furthermore, we will review the mediators of the immuno-inflammatory cascade in sepsis concerning their potential applicability as therapeutic targets in the treatment of this often lethal disease. In addition, we present some insights into the identification of genetic markers of sepsis.

(PDF emailed within 1 workday: $29.90)

Accession: 055398606

Download citation: RISBibTeXText

PMID: 21671855

Related references

Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury. Journal of Infection 72(2): 131-142, 2016

Therapeutic targets and recent advances in protein immunotoxins. Current Opinion in Microbiology 15(3): 300-309, 2013

Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact. Expert Review of Proteomics 13(4): 383-394, 2016

Sepsis in the 21st century: recent definitions and therapeutic advances. American Journal of Emergency Medicine 25(5): 564-571, 2007

Recent developments in the identification of novel therapeutic targets for the treatment of patients with sepsis and septic shock. Scandinavian Journal of Infectious Diseases 35(9): 690-696, 2003

Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World Journal of Gastroenterology 22(5): 1745-1755, 2016

Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma. Life Sciences 191: 273-282, 2017

Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets. Cns & Neurological Disorders Drug Targets 9(3): 335-348, 2010

Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. Journal of Neurology, Neurosurgery, and Psychiatry 89(2): 175-184, 2017

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378(9792): 704-712, 2011

Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets. Organogenesis 9(1): 11-18, 2014

Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges. Pharmacology & Therapeutics 177: 56-66, 2017

Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?. Expert Opinion on Drug Safety 15(5): 625-634, 2016

Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure. Pharmacological Research 76: 190-198, 2014

Recent advances in atopic dermatitis and psoriasis: genetic background, barrier function, and therapeutic targets. Journal of Dermatological Science 78(2): 89-94, 2016